Zachary H Houston

17PUBLICATIONS
60CO-AUTHORS
NanomedicinePredictive and prognostic markersGlycoconjugatesGene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 26, 2025
Harnessing nanoparticles and bioorthogonal chemistries for improving precision of nuclear medicine.

Gayathri R Ediriweera, Mengdie Li, Nicholas L Fletcher

|Feb 06, 2025
Nanobody-Mediated Cellular Uptake Maximizes the Potency of Polylysine Dendrimers While Preserving Solid Tumor Penetration.

Daniel Yuen, Orlagh M Feeney, Leo Noi

|Jan 27, 2025
Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2- Breast Cancers.

Madeline Gough, Kayden K X Kwah, Tashbib Khan

|Aug 02, 2024
A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements.

James L Wood, Saikat Ghosh, Zachary H Houston

|May 05, 2023
Development and Validation of a Targeted Treatment for Brain Tumors Using a Multi-Drug Loaded, Relapse-Resistant Polymeric Theranostic.

Weijing Chu, Zachary H Houston, Nicholas L Fletcher

|Jan 05, 2023
Pharmacokinetics and Biodistribution of 89Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma.

Saikat Ghosh, Nicholas L Fletcher, Pie Huda

Pageof 3

Frequent Collaborators

17 joint publications

Kristofer J Thurecht

12 joint publications

Nicholas L Fletcher

4 joint publications

Saikat Ghosh

4 joint publications

Craig A Bell